Article
Redefining treatment success in type 2 diabetes mellitus: Comprehensive targeting of core defects
Laurence Kennedy, MD, William T. Cefalu, MD, Robert J. Richards, MD and Lydia Y. Melendez-Ramirez, MD
Cleveland Clinic Journal of Medicine December 2009, 76 (12 suppl 5) S39-S47; DOI: https://doi.org/10.3949/ccjm.76.s5.06
Laurence Kennedy
Chair, Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic
Roles: Supplement Editor
William T. Cefalu
Joint Program on Diabetes, Endocrinology and Metabolism, Louisiana State University Health Science Center and Pennington Biomedical Research Center, New Orleans and Baton Rouge, LA
Robert J. Richards
Joint Program on Diabetes, Endocrinology and Metabolism, Louisiana State University Health Science Center and Pennington Biomedical Research Center, New Orleans and Baton Rouge, LA
Lydia Y. Melendez-Ramirez
Joint Program on Diabetes, Endocrinology and Metabolism, Louisiana State University Health Science Center and Pennington Biomedical Research Center, New Orleans and Baton Rouge, LA

Article Information
vol. 76 no. 12 suppl 5 S39-S47
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online December 1, 2009.
Copyright & Usage
Copyright © 2009 The Cleveland Clinic Foundation. All Rights Reserved.
In this issue
Cleveland Clinic Journal of Medicine
Vol. 76, Issue 12 suppl 5
1 Dec 2009
Redefining treatment success in type 2 diabetes mellitus: Comprehensive targeting of core defects
Laurence Kennedy, William T. Cefalu, Robert J. Richards, Lydia Y. Melendez-Ramirez
Cleveland Clinic Journal of Medicine Dec 2009, 76 (12 suppl 5) S39-S47; DOI: 10.3949/ccjm.76.s5.06
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.





